PMC:7408073 / 96996-97288
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T511 | 249-253 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T193 | 249-253 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3390 | 152-156 | Gene | denotes | ACE2 | Gene:59272 |
3393 | 179-182 | Gene | denotes | MLN | Gene:4295 |
3402 | 10-15 | Species | denotes | mouse | Tax:10090 |
3403 | 16-19 | Species | denotes | rat | Tax:10116 |
3404 | 70-75 | Species | denotes | human | Tax:9606 |
3405 | 76-88 | Species | denotes | participants | Tax:9606 |
3406 | 146-151 | Species | denotes | human | Tax:9606 |
3409 | 119-127 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1182 | 10-15 | http://purl.obolibrary.org/obo/CLO_0007836 | denotes | mouse |
T1183 | 70-75 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T1184 | 92-95 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T1185 | 146-151 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T1186 | 188-191 | http://purl.obolibrary.org/obo/CLO_0002096 | denotes | C16 |
T1187 | 249-253 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T33321 | 168-177 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T438 | 188-191 | Chemical | denotes | C16 | http://purl.obolibrary.org/obo/CHEBI_15756 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T471 | 0-292 | Sentence | denotes | Thanks to mouse/rat in vivo experiments and clinical trial results in human participants it has been possible to infer toxicity/efficacy for some human ACE2 inhibitory molecules (MLN-4760/C16/GL1001/ORE1001, Dx600 and A779) that may be exploited to face this exceptionally dramatic situation. |